You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Advanced Infrared Focal Plane Arrays with Strained Layer Superlattice Detectors on Digital-Pixel Readout Integrated Circuits

    SBC: QMAGIQ LLC            Topic: MDA12T003

    We propose to combine QmagiQ's strained layer superlattice (SLS) sensor technology with MIT Lincoln Laboratory's novel digital pixel readout integrated circuit (DROIC) to realize an advanced longwave infrared digital focal plane array (DFPA) with high quantum efficiency, dynamic range, and operating temperature. In Phase I, we developed the basic SLS DFPA and demonstrated its extraordina ...

    STTR Phase II 2014 Department of DefenseMissile Defense Agency
  2. A new device to improve screening of corneal transplant tissue

    SBC: Sarver & Associates Inc            Topic: NEI

    Marous, James R. An Eye Bank Endothelial Cell Counter Abstract Procurement of donor corneal tissue for transplant use is an important social service undertaken by largely underfunded eye banks. Tissue is not only harvested, but must be screened for a myriad of issues that may make the tissue unsuitable for transplant or pose a health risk to the tissue recipient. Donor tissue may be rejected for ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  3. A SORTING SYSTEM FOR IMPROVING THE QUALITY OF RECYCLED PET PLASTIC RESINS

    SBC: National Recovery Technologies LLC            Topic: N/A

    N/A

    SBIR Phase I 1995 Environmental Protection Agency
  4. Automated Identification and Sorting of Rare Earth Elements in an E-waste Recycling Stream

    SBC: National Recovery Technologies LLC            Topic: B

    Electronic waste (e-waste) is one of the most rapidly growing waste problems worldwide. Improper handling of e-waste results in vast amounts of toxic waste being sent to landfill and leaching into the water supply. Due to these concerns, e-waste recycling is a rapidly growing industry. Unfortunately, most current e-waste recycling processes rely on either manual hand sorting or differential densit ...

    SBIR Phase II 2014 Environmental Protection Agency
  5. Contamination-Free, Lightweight, Helium-Rubidium Vapor Circulation System

    SBC: CREARE LLC            Topic: MDA12018

    Diode-Pumped Alkali Laser Systems (DPALS) require a uniform, steady, flowing mixture of helium and rubidium vapor at elevated pressure and temperature. Significant challenges exist because rubidium is a very reactive material. In response, our team is developing a contamination-free, all-metal, hermetic, circulation system based on gas-bearing turbomachines. Specific benefits include low mass, ...

    SBIR Phase II 2014 Department of DefenseMissile Defense Agency
  6. Corrosion Protection of High-Value Test&Evaluation Assets

    SBC: ESPIN TECHNOLOGIES, INC.            Topic: MDA13T010

    This STTR Phase I proposal proposes to design and develop reactive filter media using nanofiber technology to capture corrosion inducing particulate matter present in coastal region air. The fibrous filter media will be functionalized using ion exchange chemistry which is known to react with salt ions. The media will be characterized for its filtration performance, resistance to airflow, and dus ...

    STTR Phase I 2014 Department of DefenseMissile Defense Agency
  7. CyanoMap: Mapping inland lake quality and Amyotrophic lateral sclerosis risk fact

    SBC: APPLIED GEOSOLUTIONS LLC            Topic: NIEHS

    DESCRIPTION provided by applicant Amyotrophic lateral sclerosis ALS is a progressive fatal neurodegenerative disease with a lifetime risk of in for a young adult Armon The average life expectancy of a person with ALS is two to five years from time of diagnosis with new cases diagnosed per year Incidence rates vary in industrialized nations an annual incidence rate of ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  8. Dampening CAR therapy-induced cytokine storm with anti-GM-CSF antibodies

    SBC: CELDARA MEDICAL, LLC            Topic: NCI

    DESCRIPTION (provided by applicant): The long-term aim of this project is to reduce or eliminate the serious adverse events associated with cellular immunotherapy used to treat cancer. The current impressive efficacy of chimeric antigen receptor (CAR) T cell therapies is often accompanied by a well-known toxicity stemming from the large release of cytokines from activated immune cells, known as a ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Destroying the HIV-1 provirus by utilizing components of the CRISPR/Cas system

    SBC: CELDARA MEDICAL, LLC            Topic: NIAID

    DESCRIPTION (provided by applicant): The goal of this project is to develop a plasmid-based therapy that will destroy the integrated HIV-1 DNA (HIV- 1 provirus) in infected cells. Current HIV-1 anti-retroviral therapy (ARV) consists of a cocktail of drugsthat blocks viral binding and replication, but does not destroy the HIV-1 provirus. In addition, ARV does not impact the large reservoir of laten ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Development of Compounds for the Prevention and Treatment of Rhabdomyolysis

    SBC: Virtual Drug Development Inc.            Topic: NIDDK

    ? DESCRIPTION (provided by applicant): The goal of this Phase I STTR project is to establish the feasibility of developing a small-molecule therapeutic agent designed to prevent rhabdomyolysis-induced renal failure. Rhabdomyolysis accounts for 7% to 10% of cases of renal failure in the US. Rhabdomyolysis results from muscle injury that leads to the release of myoglobin, which is then deposited ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government